A subscription to JoVE is required to view this content. Sign in or start your free trial.
* These authors contributed equally
This protocol presents a practical guide on the surgery for creation of aortic regurgitation (AR) in the mouse. Assessment of the AR mouse by echocardiography and invasive hemodynamic measurement recapitulates its clinically relevant characteristics of volume overload-induced eccentric hypertrophy, suggesting its promising application in the study of cardiac hypertrophy.
Aortic regurgitation (AR) is a common valvular heart disease that exerts volume overload on the heart and represents a global public health problem. Although mice are widely applied to shed light on the mechanisms of cardiovascular disease, mouse models of AR, especially those induced by surgery, are still paucity. Here, a mouse model of AR was described in detail which is surgically induced by disruption of the aortic valves under high-resolution echocardiography. In accordance with regurgitated blood flow, AR mouse hearts present a distinctive and clinically relevant volume overload phenotype, which is characterized by eccentric hypertrophy and cardiac dysfunction, as evidenced by echocardiographic and invasive hemodynamic evaluation. Our proposal, in a reliable and reproducible manner, provides a practical guide on the establishment and assessment of a mouse model of AR for future studies on molecular mechanisms and therapeutic targets of volume overload cardiomyopathy.
In the presence of increased volume overload (preload) or pressure overload (afterload), the heart undergoes enlargement, a condition termed hypertrophy. Although cardiac hypertrophy is a compensatory response to maintain perfusion of peripheral organs before cardiac failure, it is also an independent risk factor for major cardiovascular events1,2. Volume overload is one of the important manifestations of increased mechanical stress. Volume overload occurs during cardiac diastole and induces eccentric cardiac hypertrophy, which is not only commonly seen in valvular diseases, such as aortic regurgitation and mitral regurgitation, but also in end-stage hypertensive heart disease, myocardial infarction, dilated cardiomyopathy, and excessive exercise. In addition, in clinical practice, some drugs that can better reduce the myocardial hypertrophy induced by pressure overload have unsatisfactory effects in the treatment of myocardial hypertrophy induced by volume overload1. It is therefore of great significance to discover the mechanism and intervention methods of eccentric cardiac remodeling caused by volume overload. However, such research on volume overload has been significantly hampered for a long time, which can be, in large part, attributed to the lack of small animal models that can be easily operated, efficiently quantified, and stably replicated3.
As for small animal species, mice have become the mainstream model animal for cardiovascular disease research due to their short life cycle, convenient operation, clear genome, and ease of genetic modification4. In terms of model categories, compared to genetic modification models and drug-treated models, surgical models have obvious unique advantages. The surgical model can avoid excessive and laborious mouse breeding and gene identification that are necessary for the genetic modification model and can also avoid the non-specific effects on extracardiac tissues and organs that are difficult to control in drug-treated models. The mouse model of aortocaval shunt has been documented to induce cardiac volume overload in previous literature5. However, aortocaval shunt accounts for a small fraction of cardiac eccentric hypertrophy in the clinic and causes biventricular overload5, making it of little translational significance to be used in left ventricular eccentrical hypertrophy study. Nevertheless, valvular heart disease represents a major public health problem worldwide; it is estimated that around 15% of the population >75 years of age has significant valvular disorder6. Although aortic regurgitation (AR) occupies a portion of valvular heart disease, it distinctively causes eccentric left ventricular (LV) hypertrophy due to an increase in volume overload by regurgitant blood flow7,8. Considering the right common carotid artery (RCCA) provides a route to reach the location of aortic valves, it is conceptually intriguing to disrupt aortic valves via the RCCA to cause regurgitant blood flow in mice. Inspired by the techniques of creating oscillating aortic flow9, a mouse model of aortic regurgitation (AR) was recently established in our lab to surgically induce volume overload7. This AR mouse demonstrates obvious LV eccentric hypertrophy, which is a clinically transformative approach and demonstrates a great translational potential for studying the overloaded heart phenotype and its underlying mechanism. Here, a detailed step-by-step procedure was described to perform AR surgery in mice, recapitulated by high frequency echocardiography and invasive hemodynamics to ensure the success of the surgery (Figure 1).
This protocol has received ethical approval from the Animal Care and Use Committee of Zhongshan Hospital, Fudan University, and follows the recommendations of Guide for the Care and Use of Laboratory Animals (No. 85-23, revised 2011; National Institutes of Health, Bethesda, MD, USA).
NOTE: Animal experiments were performed on male C57BL/6J mice >10 weeks of age. The surgeon in this protocol should be skillful in the manipulation of murine echocardiography, before he/she performs the AR operation in the mouse. However, at most research institutions, small rodent echocardiography is operated by a core facility, so the surgeon can closely collaborate with core experts, if not an experienced surgeon in echocardiography. Experience of invasive hemodynamic measure in mouse is a plus.
1. Preparation for ultrasound imaging (mandatory) and invasive hemodynamic measurement (optional)
2. Anesthesia of mice, preparation of surgical devices, and isolation of the RCCA
NOTE: Surgical tools must be sterilized and autoclaved before use. All steps are recommended to be performed under aseptic conditions. It is also recommended that hair removal is performed 1 day ahead to save time during the imaging procedure, minimize potential undesired stress responses in the mice, and to keep the chest and extremities clean and dry.
3. Catheterization through the RCCA and ascending aorta under ultrasound guidance
4. Puncture of the aortic valves under ultrasound guidance
5. Withdrawal of the plastic catheter and metal wire, and perioperative care
6. Sham surgery
7. Assessment of aortic valve perforation, cardiac morphology, and function using echocardiography and invasive hemodynamic measurement
To guarantee successful AR, we validated regurgitant blood flow using color Doppler and pulse wave Doppler echocardiography. In mice with AR, the color Doppler spectrum of the aortic arch showed regurgitant flow (red) immediately post-operation, which was absent in sham mice (no flow in diastole; Figure 3A). Consistently, the pulse wave Doppler demonstrated robustly elevated regurgitant flow in AR mice (Figure 3B,C). With a further confirmation ...
The surgical induction of AR in the mouse is a technically challenging, new technique but has significant translational relevance. To master the technique, a surgeon should at least be familiar in advance with murine cervical and cardiac anatomy, mouse handling, and echocardiography. Skillful operation in invasive hemodynamic measurement is a plus. For successful AR operation, special care should be taken on several critical steps.
Cutting open the RCCA is the most crucial step. The hole on th...
The authors have no conflicts of interest to disclose.
This work was supported by the National Natural Science Foundation of China (81941002, 82170389, 82170255, 81730009, 81670228, and 81500191), Laboratory Animal Science Foundation of Science and Technology Commission of Shanghai Municipality (201409004300 and 21140904400), Health Science and Technology Project of Shanghai Pudong New Area Health Commission (PW2019A-13), and "Rising Sun" Excellent Young Medical Talents Program of Shanghai East Hospital (2019xrrcjh03).
Name | Company | Catalog Number | Comments |
Copper plate | JD.com Inc. | Customized | 20 X 15 cm or bigger is prefeered |
Curved Tying forceps | 66 Vision Tech | 53324A | to stretch and isolate muscle, tissue, and vessel |
Heating pad | JD.com Inc. | Changzhi 55 | warm the copper plate and mouse by the way |
Long-handed Curved Tying Forceps | MECHENIC | TS-15 | to stretch vessel |
Metal Wire (stainless steel) | JD.com Inc. | 0.18 mm in diametter | work with a plastic catheter to puncture aortic valves |
Needle Holder | Shanghai Jinzhong | 131110 | suture of skin |
Plastic Catheter | Anilab software & instruments | PE-0402 | work with a metal wire to puncture aortic valves |
Pressure Catheter | Millar Instruments | SPR 835 | 1.4F in size |
Pressure Data Acquisition Device and Analog/Digital Converter | AD Instruments | Labchart 5 | connected with pressure catherter |
Scissor | Suzhou Shiqiang | Stronger 13Cr | to cut skin |
Smallpinch Scissors | Shanghai Jinzhong | YBE030 | to cut vessel |
Stereomicroscope | Olympus Corporation | SMZ845 | for incision and intubation of vessel |
Straight Tying forceps | 66 Vision Tech | 53320A | to stretch and isolate muscle, tissue, and vessel |
Thumbforceps | Suzhou Shiqiang | 5307B | to clamp and stretch skin and muscle |
Ultrasound Gel | PARKER | Aquasonic-100 | to transfer ultrasound signal |
Ultrasound Imaging System | VisualSonics | 2100 | includes B-mode, M-model, color Doppler and pulse wave Dopper |
Vaporizer | RWD Life Science | R540 | for anesthesia |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved